Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized microglial immune cells that the companies plan to use toward revealing significant new targets in neurodegenerative diseases. The post Recursion, Roche Unveil Microglia Map of Neuro Disease Targets appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
A computational method was developed to create synthetic receptors called T-SenSERs that are engineered to detect soluble signals found in tumors and convert them into co-stimulatory or cytokine-like signals that boost anticancer T cell activity. The post Computationally Designed Receptors Help Engineered T Cells Control Tumors appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
In the blink of an eye, twenty years have passed: in mid-October 2005, I joined Atlas Venture as a principal on the global life science team. We closed Fund VII a few months after I joined; and, just a few The post Twenty Years In Early Stage Biotech VC (Part 1): Science appeared first on LifeSciVC.| LifeSciVC
Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for peptides? The post The advent of AI for peptide design: An emerging field appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given ...| Labiotech.eu
PapB 'ties off' peptides, paving way for stronger, longer-lasting versions of medications used to treat obesity and diabetes.| @theU
Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19.| wertheim.scripps.ufl.edu
Experts from across the pharmaceutical and biotechnology landscape share trends, challenges, and opportunities for using AI in drug discovery. The post AI in Drug Discovery: Key Insights from a Computational Biology Roundtable appeared first on Digital Science.| Digital Science
From willow bark to Nobel Prize-winning malaria treatments, ancient plant remedies that have withstood scientific scrutiny continue to fuel breakthrough medical discoveries in the modern world. When my dermatologist suggested…| The Pipettepen
Discover groundbreaking research on Alzheimer's that reverts the disease in mice using innovative nanotechnology strategies.| Drug Target Review
Eli Lilly’s TuneLab shares AI drug discovery models with biotech partners, aiming to speed pharmaceutical R&D through collaboration and machine learning.| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
By Ram Aiyar, CEO of Korro Bio, as part of the From The Trenches feature of LifeSciVC Let me tell you a secret that most biotech executives won’t admit at cocktail parties: we’re all making it up as we go The post Speed Wins: The Focused-Team Formula for Platform Biotechs appeared first on LifeSciVC.| LifeSciVC
Effective long-term follow-up in vaccine clinical trials is crucial. Explore key considerations for study design, patient tokenization, and regulatory compliance.| Drug Discovery and Development
Antibodies from a person who had previously been infected with mpox provides full protection from severe illness and death in mice.| GEN - Genetic Engineering and Biotechnology News
Tarsus aims to expand the lotilaner pipeline with potential treatments for ocular rosacea, Lyme disease and malaria.| Drug Discovery and Development
Bispecific antibodies are a rapidly advancing class of therapeutics, offering a new level of precision in treating diseases like cancer.| Drug Discovery and Development
The movement of epithelial cells during wound healing is mediated by the endoplasmic reticulum, which senses the curvature of wound gaps.| GEN - Genetic Engineering and Biotechnology News
VantAI's AI platform will accelerate programmable protein interaction therapies across Halda's cancer and immunology indications.| GEN - Genetic Engineering and Biotechnology News
Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.| GEN - Genetic Engineering and Biotechnology News
As scientists, we are accustomed to learning something new about targets (and the modulation thereof) that moves the field forward...| HotSpot Therapeutics
NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?| Labiotech.eu
Liu’s research focuses on the discovery of small molecules for human proteins, as well as the functional characterization of these proteins in physiological and disease contexts.| wertheim.scripps.ufl.edu
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
Alex Tropsha is part of a multi-million dollar, federally funded project using machine learning to identify new uses for existing drugs.| UNC Research Stories
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
The once pioneering DNA test company 23andMe is now a penny stock that has filed for bankruptcy. Its CEO Anne Wojcicki is also stepping down.| Drug Discovery and Development
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.| The Stanford Daily
Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors. It’s a condition without any treatments, one that’s hard both on parents and children, said Gavin Rumbaugh, Ph.D., a neuroscientist at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation &…| wertheim.scripps.ufl.edu
In the perpetual and never-ending race by the healthcare sector to unearth new approaches and therapeutics to address disease, one...| HotSpot Therapeutics
$1B women's health push and RNAi advances mark JPM 2025, with solid tumor therapies gaining momentum| Drug Discovery and Development
PubMiner AI aims to help researchers in the biomedical domain overcome the challenges in automatic knowledge extraction from large volumes of scientific publications. The post Advancing Automatic Knowledge Extraction with PubMiner AI appeared first on Ontotext.| Ontotext
Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health.| Labiotech.eu
Dr. Hendrik Luesch’s new joint appointment will expand UF’s natural products research to one of the world’s prime areas for marine biodiversity.| pharmacy.ufl.edu
Discover how multivariate analysis is transforming target identification in cancer drug discovery by moving beyond traditional methods.| Labiotech.eu
A new computational screening system using AI could lead to more efficient, cost-effective and expansive search for novel therapeutic drugs.| Promega Connections
At HotSpot, we’re harnessing insights from nature by pinpointing specialized protein on/off switches, or pockets, called “natural hotspots.” To date,...| HotSpot Therapeutics
Signaling pathways are the intricate networks that govern cell behavior, lying at the crux of cell function. They are used...| HotSpot Therapeutics
At HotSpot, we are committed to building something we believe is truly distinctive, setting ourselves apart from our peers in...| HotSpot Therapeutics
Every company has a culture, either by design or default. From our inception in 2016, we wanted to create a...| HotSpot Therapeutics
The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...| HotSpot Therapeutics
